Help us: Donate
Follow us on:
×

Tag: Alex Zhavoronkov

October 16, 2020
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on AI-powered drug discovery focused on identifying molecules to remove problematic senescent cells. Cellular SenescenceAs your body ages, more of your cells...
September 18, 2020
A new app created by Hong Kong-based Deep Longevity might help you stay in your prime longer, keep your mind sharp, and maintain habits that keep your biological age lower than your chronological age. Introducing Young.ai It has been an increasing trend in recent years for companies to develop health and fitness apps that track...
May 08, 2020
Few things in aging research are ever straightforward, and today's topic is no exception, as two researchers enjoy some back and forth regarding whether and how the World Health Organization (WHO) should recognize the aging processes as a disease. Proposing a new framework to facilitate development of rejuvenation therapies Back in November 2019, an international...
April 22, 2020
In this 80-minute interview with Brent Nally, Dr. Alex Zhavoronkov of Insilico Medicine discusses the relationship between COVID-19 and age-related diseases, including how this 'gerophilic' disease primarily afflicts the elderly, how COVID-19 has affected research on aging, and many related topics, including how extending lifespan without extending healthspan puts our society at risk of hyperinflation...
January 29, 2020
The coronavirus epidemic is spreading from China into other countries, so here is what life extensionists should know about this situation and how they should handle it. A few months ago, we interviewed Dr. Jay S. Olshansky, a leading demographer from the School of Public Health at the University of Illinois at Chicago, whose areas...
December 05, 2019
A type of artificial intelligence technique is now being used to develop new drugs and therapies and could perhaps even help to solve aging. An urgent need for aging biomarkers There has long been an urgent need in our field to develop increasingly accurate biomarkers of aging so that the efficacy of interventions can be...